Skip to main content
Full access
Articles
Published Online: 15 December 2017

Correlates of Reduced Violent Behavior Among Patients Receiving Intensive Treatment for Posttraumatic Stress Disorder

Abstract

Objective:

Posttraumatic stress disorder (PTSD) has been linked to violent behavior, especially among military personnel returning from service in a war zone. Little is known, however, about whether the extent of violent behavior among persons with PTSD changes in response to intensive treatment or about the predictors and correlates of any such change.

Methods:

The study examined data from over 35,000 U.S. military veterans treated in specialized intensive Veterans Health Administration PTSD programs. Data were collected at program entry and four months after discharge. Variables studied documented sociodemographic and biographical data, program participation, and clinical factors such as PTSD symptom severity and substance use. Violence was assessed by a self-report measure that addressed property damage, threatening behavior, and physical assault.

Results:

Violence declined significantly between program entry and four-month postdischarge, with a moderate effect size. Most of the variance was explained by baseline levels of violence; those who reported the most violent behavior at baseline showed the largest reductions four months after discharge. The reduction in violence was more strongly correlated with reductions in patients’ PTSD symptomatology and substance use than with their incarceration history or with other sociodemographic and biographical variables.

Conclusions:

Although an observational study cannot identify specific causes of reductions in violent behavior, these data suggest that the short-term support, shelter, and asylum that formed part of intensive treatment are associated with reduced violent behavior and that such services play an important role in the spectrum of care for war-related PTSD.
Violent behavior among veterans returning from service in a war zone has been of concern since the 1960s and 1970s, when accounts of violence among returning Vietnam veterans began appearing in the popular media (1). Research showed that 46% of these veterans had committed at least one violent act in the 12 months prior to assessment and that 37% had committed six or more such acts (2).
Different studies use different outcome variables, making it difficult to compare rates of violence in recent reports. Higher rates of violence are usually reported among veterans with PTSD than in veterans without PTSD. When violence is defined as self-reported kicking, slapping, or getting into fights, the annual rate among U.S. veterans returning from Afghanistan and Iraq with PTSD, 48%, is 2.3 times that for veterans without PTSD (3). Violence is less prevalent when defined as criminal conviction for a violent offence, but the increase in violence risk associated with clinical PTSD (7.3% versus 3.2%) appears to be the same (4). Research on civilian populations similarly shows higher rates of violence among people with PTSD than in population controls (5).
Identifying potential mediators of the link between PTSD and violent behavior is a natural next step toward developing effective interventions, but it has been the subject of only limited research. Veterans with PTSD score higher on measures of anger than do veterans with other psychiatric diagnoses (69). Alcohol abuse is common among persons with PTSD, and alcohol use and PTSD together have been shown to be associated with a greater risk of violent behavior compared with either alone (4,10), especially for serious violence (3). Evidence of the contribution of specific PTSD symptom clusters to violent behavior has been inconsistent. Early research implicated numbness (11), but recent studies with larger samples suggest that hyperarousal has a stronger effect (4). Both the overall number and the overall severity of PTSD symptoms are important correlates of violence (4).
We are not aware of any studies that have described reductions in violent behavior following treatment aimed specifically at PTSD and its component symptom clusters. As a consequence, questions relating to which forms or elements of treatment are most likely to reduce violence and which symptom clusters may be the most promising targets for intervention remain unanswered. We sought to identify aspects of patients’ clinical condition, treatment variables, and indicators of PTSD symptom change that were most strongly associated with changes in violent behavior.

Methods

Sample and Data Collection

Data were obtained from an administrative program evaluation of U.S. combat veterans treated in Veterans Health Administration (VHA) specialized intensive PTSD treatment programs throughout the United States between 1993 and 2011. The evaluation was conducted by the VHA’s Northeast Program Evaluation Center (NEPEC). Patients were excluded from the study if they had been admitted to the PTSD program from an inpatient or a residential setting. The intensive treatment programs were provided in day hospitals, short-term acute care admission units, specialized intensive inpatient units, and extended-stay residential treatment facilities. All provided daily treatment. The programs and overall sample characteristics have been described previously (1214).
Patients received structured baseline assessment at the time of entry to the treatment program and follow-up evaluation four months after discharge. Evaluations were conducted by staff of the treating programs who were not directly involved in the treatment of the particular veterans whom they were assigned to assess. At program entry, data covering sociodemographic and other background information were collected. Data on clinical factors (including PTSD symptoms and substance use), treatment participation, and violent behavior were collected at both time points. Diagnoses and ratings of treatment commitment and treatment participation were based on assessments by program staff. All other data, including clinical measures, relied on patient self-report. The study was approved and given a waiver of informed consent by the U.S. Department of Veterans Affairs Connecticut Health Care System Institutional Review Board.
Patients for whom follow-up data were available did not differ significantly on measures of baseline violence compared with patients with no follow-up data. A stepwise logistic regression showed that the four factors most strongly associated with being lost to follow-up were younger age, clinician ratings of less commitment to treatment at the time of discharge, involuntary discharge for breaking rules, and voluntary discharge against professional advice.

Measures

Violence was assessed at program entry and at follow-up. We used participants’ responses on four items from the National Vietnam Veterans’ Readjustment Study (2). The items asked whether in the past four months the patient had destroyed property, threatened someone with physical violence (without a weapon), had a physical fight with someone, or threatened someone with a weapon. We developed a combined measure of violence by adding together the responses on these four dichotomous questions (yes=1, no=0; possible scores range from 0 to 4). On program entry, the raw and standardized Cronbach alpha coefficients for the items in the combined measure were both .71 (15). For the same measure at follow-up, the raw and standardized alpha coefficients were .68 and .70, respectively.
Background information included age, gender, educational achievement as measured by number of years of full-time education, self-defined race, and marital status. For history of incarceration, a 3-point index was created to reflect whether a patient had been incarcerated for two weeks or more, less than two weeks, or never (score of 2, 1, or 0, respectively). For employment, a 3-point index was generated to indicate whether a veteran was engaged in full-time work, was engaged in part-time work, or was unemployed (score of 2, 1, or 0, respectively). Over the course of the study, the structural emphasis of these treatment programs changed from extended inpatient stays to brief inpatient treatment, nonmedical residential settings, and day hospital programs (16). Year of entry to the PTSD treatment program was recorded as a proxy measure of this changing program emphasis.
At program entry it was recorded whether the patient had been prescribed medication over the past 30 days and any comorbid diagnoses in addition to PTSD. Three features of a patient's participation in the treatment program were recorded at discharge: length of stay in days, the patient’s commitment to treatment during the program (rated by the primary clinician), and treatment outcome (also rated by the primary clinician: successfully completed the program; transferred to a non-PTSD treatment program, typically a hospital; asked to leave for reasons related to rule breaking, most commonly substance use; chose to leave of his or her own accord; or left because of general medical illness).
Alcohol and drug abuse were assessed using composite measures from the Addiction Severity Index (ASI) (17). PTSD symptomatology was assessed at program entry and follow-up with the 14 items of the short form of the Mississippi Scale for PTSD (MISS) (18) and the four items that constitute the NEPEC PTSD assessment tool (13). All items addressed symptoms and behavior during the previous four months. We generated a combined measure of total PTSD severity and six subscales by using all items from the short MISS and the NEPEC scale. Cronbach’s alphas for the 18 items contained in the combined measure were .78 (raw) and .81 (standardized). The six subscales, based on face value interpretation of the items, assessed numbness, arousal, re-experiencing, avoidance, suicidal thoughts, and irritability.
We generated a measure of change in violent behavior by subtracting the results of the baseline assessment from the results of the follow-up assessment. Thus negative values represented reduced violent behavior, and positive values represented increased violent behavior. Change scores were also constructed for the ASI composite alcohol and drug use measures, for the total PTSD scale and each of the six subscales, and for the ASI employment subscale (17), again by subtracting the score at program entry from the score at follow-up.

Statistical Analyses

The analyses were designed to identify correlates of change in violent behavior between program entry and follow-up.
Bivariate correlations were used to identify individual variables that were correlated with change in violence between program entry and follow-up. Because regression to the mean will lead to greater change in violent behavior among veterans with more violent behavior at baseline, we used models that controlled for the values of the violence measures at program entry. We used the same approach in our analysis of clinical change at follow-up. When examining the relationship between change in PTSD symptoms and change in violence, for instance, we controlled for the baseline levels of both PTSD and violence.
All of the variables that were significantly associated with change in violent behavior in these bivariate correlations were then entered into a stepwise regression to identify variables that were independently associated with a change in violent behavior. Baseline measures that were significantly associated with change in violence were forced into the model before the change variables were entered. We further examined a series of four stepwise logistic regression models to evaluate outcomes for each of the four dichotomous violent behavior items constituting the total scale, controlling for the baseline value of each.
We curtailed the addition of variables to the stepwise regression at the point where further variables contributed less than .5% to the cumulative adjusted R2. This choice of threshold was based on a calculation of the implications of a .5% increase in R2 for the associated change in the dependent variable (violent behavior) when measured in units of standard deviation (SD). A change of .5% in the adjusted R2 corresponds to a change in violent behavior of .003 SDs. By conventional criteria, this is below the level of “small” change (19).
All analyses were performed by using SAS, version 9.3, statistical software (20).

Results

Descriptive information about the sample appears in Table 1. Data were available for 35,330 patients at the time of program entry and for 24,099 patients (68.2%) at follow-up, four months after discharge. At program entry, data on violence in the past four months were available for 33,809 patients; 44% (N=14,876) reported that they had destroyed property at some point in the past four months. This figure declined to 23% (N=7,776) at follow-up. At program entry, 58% reported threatening someone without a weapon, 30% reported being involved in a physical fight, and 17% reported threatening someone with a weapon in the past four months. These figures declined to 40%, 15%, and 8%, respectively, at follow-up.
TABLE 1. Characteristics at baseline of 35,330 U.S. combat veterans treated in VHA specialized PTSD treatment programs between 1993 and 2011a
CharacteristicTotal NN%
Background variable   
 Age (M±SD)34,87451.0±9.8 
 Male24,78723,79696
 Highest level of education (M±SD years)35,25612.9±2.1 
 White35,24525,02471
 Married35,33014,83942
 History of incarceration (M±SD)b35,249.70±.81 
 Employed (M±SD)c35,262.33±.71 
 Program entry year (M±SD)33,4562002±5.3 
Clinical status at program entry   
 ASI score (alcohol) (M±SD)d33,802.128±.24 
 ASI score (drug) (M±SD)d33,797.049±.09 
 Prescribed medication35,26129,97285
 Diagnoses in addition to PTSD   
  Alcohol abuse28,93816,78458
  Drug abuse35,19126,39375
  Anxiety disorder35,17930,95888
  Affective disorder35,17925,32972
 PTSD subscale score (M±SD)e   
  Numbness33,8443.65±.48 
  Arousal33,8633.42±.56 
  Re-experiencing33,8633.84±.73 
  Avoidance33,8214.10±.92 
  Suicidal thoughts33,8632.70±.98 
  Irritability33,8283.73±1.00 
 Total PTSD symptom score (M±SD)e33,8633.53±.45 
a
PTSD, posttraumatic stress disorder. VHA, Veterans Health Administration
b
Rated as 0, never incarcerated; 1, incarcerated for less than two weeks; or 2, incarcerated for more than two weeks
c
Rated as 0, unemployed; 1, engaged in part-time work; or 2, engaged in full-time work
d
ASI, Addiction Severity Index. Possible scores range from 0 to 1, with higher scores indicating greater severity.
e
Possible scores range from 0 to 1, with higher scores indicating more symptoms.
The mean±SD total violence score on program entry was 1.49±1.34. The mean total violence score at follow-up was .91±1.42. The mean change in the violence score from baseline to follow-up (–.58) generated an effect size of –.44. In other words, mean violence at discharge was .44 SDs below the mean violence at program entry. This represents moderate effect size by Cohen’s criteria (19).
After controlling for baseline values of violence and baseline values of all other change measures, we found that many of the background measures were significantly associated with reduction in violence on bivariate analysis (Table 2). The regression coefficients were moderate in size. Thus increased age, being male, educational attainment, being white, being married, and year of program entry were associated with greater reduction in violence (as indicated by a negative coefficient) between treatment entry and follow-up than was the case for the group as a whole, and having a history of incarceration was associated with a smaller reduction in violence (as indicated by a positive coefficient).
TABLE 2. Correlates of change in violent behavior between program entry and follow-up among 24,099 U.S. combat veterans treated for PTSDa
    Regression coefficientb
CharacteristicTotal NN%rp
Background variable     
 Age (M±SD)23,76551.02±9.78 –.068<.001
 Male15,96215,32496–.022<.001
 Highest level of education (M±SD years)24,05912.94±2.15 –.019<.001
 White24,09917,11071–.019<.001
 Married24,09910,84545–.016.001
 History of incarceration (M±SD)c24,059.70±.81 .041<.001
 Employed on program entry (M±SD)d24,066.33±.71 .006ns
 Program entry year (M±SD)23,9943.11±4.51 –.032<.001
Clinical status on program entry     
 Prescribed medication24,05920,45085–.002ns
 Diagnosis in addition to PTSD     
  Alcohol abuse18,95010,99158.015<.01
  Drug abuse24,05118,03875.016<.01
  Anxiety disorder24,04621,16088–.001ns
  Affective disorder24,03717,30772.000ns
Treatment participation     
 Length of stay in treatment (M±SD days)23,99344.38±25.85 –.020<.001
 Commitment to treatment (M±SD)e23,9692.74±.84 –.048<.001
 Completed treatment23,93221,77891–.024<.001
 Noncompletion     
  Transfer (for example, to hospital)23,9323591.5–.009ns
  Rule-breaking termination23,9327183.0.025<.001
  Voluntary termination23,9329093.8.019<.001
  Physical illness23,93248.2.003ns
Clinical change with treatment (M±SD)f     
 Change in employment status scored23,996.00±.21 –.031<.001
 Change in ASI score (alcohol)g24,040.00±.21 .203<.001
 Change in ASI score (drug)g24,027.00±.09 .163<.001
 Change in PTSD scoreh     
  Numbness24,090–.12±.60 .225<.001
  Arousal24,098–.18±.67 .237<.001
  Re-experiencing24,098–.21±.76 .260<.001
  Avoidance23,980–.21±1.14 .192<.001
  Suicidal thoughts24,040–.29±1.02 .312<.001
  Irritability24,005–.25±1.10 .311<.01
  Total PTSD symptomsh24,098–.19±.53 .327<.001
a
The veterans were treated in Veterans Health Administration specialized posttraumatic stress disorder (PTSD) treatment programs between 1993 and 2011.
b
Expressed as a standardized estimate and adjusted for violent behavior at program entry
c
Rated as 0, never incarcerated; 1, incarcerated for less than two weeks; or 2, incarcerated for more than two weeks
d
Rated as 0, unemployed; 1, engaged in part-time work; or 2, engaged in full-time work
e
Rated by the primary clinician on a 5-point scale, from 1, not at all, to 5, maximally
f
Analyzed with program entry values as covariables to address regression to the mean
g
ASI, Addiction Severity Index. Possible scores range from 0 to 1, with higher scores indicating greater severity.
h
Possible scores range from 0 to 5, with higher scores indicating more symptoms.
Measures of clinical status at the time of program entry, with the exception of substance abuse diagnoses, where the regression coefficients were very small, were not significantly correlated with a change in violence at follow-up. Measures of treatment participation (length of stay, commitment to therapy as rated by program staff, and successfully completing the program) were significantly correlated with a change in violence at follow-up, but the regression coefficients were again small.
Larger, positive, regression coefficients were evident for the measures of clinical change between intake and follow-up. Improved employment (that is, a positive value for the change variable), reduced alcohol use and reduced drug use (a negative value for the change variable) were associated with a reduction in violence beyond what would have otherwise been attributed to baseline status and regression to the mean. Reductions in PTSD symptoms (reflected in negative values for the change variables) were also positively correlated with reductions in violence beyond those for the sample as a whole. This was the case for both individual subscales and total PTSD score.
When expressed as standardized estimates, regression coefficients allow effect size to be calibrated in terms of SDs. Table 2 shows that a reduction in the total PTSD score of one SD (for example, from its mean at program entry of 3.5 to 3.0) was associated with a reduction in the violence score at follow-up of .327 SDs (for example, from its mean at follow-up of .91 to .46).
The results of the stepwise regression are shown in Table 3. The largest contributor to the adjusted R2 was violence at program entry, with a large negative coefficient showing that higher baseline levels of violence were associated with greater reductions in violence at four-month follow-up. Measures of alcohol use, drug use, and unemployment at program entry made small contributions to the adjusted R2, with a somewhat larger contribution coming from overall PTSD symptoms at program entry. The only change variable contributing significantly to the change in adjusted R2 was a change in alcohol use between program entry and follow-up.
TABLE 3. Stepwise regression of variables that were significantly associated with change in violent behavior among 24,099 U.S. combat veterans treated for PTSD
VariableAdjusted R2Regression coefficienta
rp
Intercept00<.001
Violence at program entry.437−.692<.001
ASI score (alcohol) at program entryb.437.139<.001
ASI score (drug) at program entryb.437.009ns
Employed at program entry.437−.003ns
Total PTSD score at program entry.440.053<.001
Change in ASI score (alcohol).462.200<.001
a
Expressed as a standardized estimate
b
ASI, Addiction Severity Index
Stepwise logistic regression models examining separately the four dichotomous violence items at follow-up confirmed that a reduction in alcohol use remained significantly associated with a reduction in each violent behavior.

Discussion

This study showed that scores on a standard measure of violent behavior declined significantly in a sample of combat veterans treated in specialized intensive PTSD treatment programs between entry into a program and four months postdischarge with a moderate effect size (r=–.44). The correlations between changes in violent behavior and clinical variables, including changes in PTSD symptoms and substance use, have not been demonstrated previously in a sample of veterans receiving intensive treatment. Several aspects of the results warrant further comment.
First, the reduction in violence in this study was somewhat smaller in magnitude for patients who were younger, female, less educated, nonwhite, and not married; who had a history of incarceration; and who been abusing alcohol or drugs when they entered treatment. Female gender has elsewhere been found to be a protective factor against violence, although in mental health samples this effect is often lost as it was here (21,22). The remaining variables that were associated with smaller reductions in violence have consistently been shown to be associated with violent behavior in a range of samples and settings (23,24). We have shown that these variables were also associated with less decline in violence following treatment.
Second, the move away from long-term inpatient treatment in the VHA, as reflected in the year of program entry, was associated with a small but significantly greater reduction in violent behavior. This is consistent with evidence from other studies that the move away from long-term inpatient treatment for PTSD has led to greater clinical improvement, both at discharge and follow-up (15). On the other hand, we found little evidence that treatment participation—as measured by length of stay, commitment to treatment, or successful completion of the program—was associated with substantial reductions in violent behavior. The effect sizes were small and not significant in multivariate analysis. Treatment may have had benefits that were not detected by these therapy-related measures.
Third, on bivariate analysis the reduction in violence was greatest for patients with reductions in substance use and PTSD symptoms. Reduced alcohol use and PTSD symptoms at program entry were further associated with a reduction in violence on multivariate analysis. While the strongest single correlate of reduced violence at follow-up on multivariate analysis was violence at program entry, taken together, these results support targeting PTSD symptoms and substance use when seeking to reduce violence among veterans with PTSD. Intensive treatment may have benefited these patients either because medication and psychotherapy reduced violence directly or, more likely, because treatment reduced the PTSD symptoms and substance use that increased the risk of violence. Some symptom reduction, for instance in re-experiencing and avoidance, may reduce vulnerability to environmental triggers of violence among persons with PTSD. Other changes with treatment, for instance, reduced arousal and irritability, seem likely to improve resilience more generally.
Finally, the decline in violence was most strongly associated with reductions in irritability, suicidality, and re-experiencing and with total PTSD symptom scores. While this bivariate finding was not preserved on multivariate analysis, it lends some support to research linking these symptom clusters to violence and suggesting that PTSD symptoms have a cumulative effect on violence risk (4). Further analysis of the PTSD and substance use change measures showed a high level of intercorrelation (α=.75), suggesting that these change measures reflect a common underlying construct. Patients who drank in part to relieve the distress and arousal of PTSD may have abused alcohol less as these symptoms improved.
Several limitations require acknowledgment. First, because violent behavior is a major reason that individuals with PTSD seek and are admitted for treatment (11), the overall reduction in violence is likely to reflect, at least in part, regression to the mean. Within the overall reduction in violent behavior we have identified variables correlated with greater and lesser reductions. We sought to control for the effect of regression to the mean on these correlations by including violence at program intake as a covariate in the regression analyses. Doing so is not a substitute for an intervention study that randomly assigns patients to treatment and control groups, however. Conclusions regarding causality from these data must be correspondingly cautious.
Second, we have examined the reduction in violence following treatment in a heterogeneous set of programs that used a range of forms of psychotherapy and medication. Although there was also some consistency across sites (for instance, all of these programs provided daily treatment in an inpatient, residential, or day hospital setting to U.S. veterans of recent military service), future research should seek to distinguish the effects of specific therapies and program structures both on symptomatic improvement and on violence risk. Third, we used self-report as the basis of our violence measure. Confirming these reports with official records of arrest and conviction, as well as information from collateral sources, would increase the validity of the outcome measure.
Finally, only a subset of veterans with a diagnosis of PTSD receives mental health services from the VHA, and, of this subset, only a smaller subset receives intensive PTSD treatment. The generalizability of the findings to other kinds of trauma and to women is unknown. Some factors associated with being lost to follow-up, such as younger age, were also related to violence. Although these associations do not demonstrate a bias in our analyses, we cannot exclude the possibility that the results would have been different had follow-up data been collected for all patients.
Previous suggestions that clinical variables are relatively unimportant correlates of violent behavior among samples of persons with a mental disorder (23) are not supported by this study. Not all of the treatment variables that we studied were equally relevant however. Length of stay and perceived commitment to treatment were less strongly associated with a reduction in violent behavior than changes in other clinical phenomena, such as improvements in substance abuse and PTSD symptoms. Most of the significant correlations between violent behavior and clinical variables were no longer significant on multivariate analysis. This suggests that the clinical variables are strongly intercorrelated, a finding consistent with clinical experience.
The mean length of stay in these programs was 44 days. Despite the move away from long-term inpatient psychiatric treatment in the VHA (25) and elsewhere in the U.S. mental health system (26), patients may have experienced benefits not just from treatment but also from nonspecific factors such as shelter, support, and respite from the cumulative effect of life stresses. If so, the benefit of this support for reduced violence remained evident four months after discharge. The role of intensive residential or inpatient treatment has been downplayed in mental health care in recent years, largely for economic reasons. This study suggests that the benefits of specialized intensive PTSD treatment, perhaps in turn reflecting the broader benefits of “asylum,” should not be ignored.

Conclusions

In this study of U.S. veterans receiving intensive treatment for PTSD, reduction in violence during and after treatment was more strongly correlated with reductions in patients’ PTSD symptomatology and substance use than with incarceration history or with sociodemographic and biographical variables traditionally associated with violence. The results suggest that the support, shelter, and asylum that are part of intensive treatment are associated with reduced violent behavior and that such services play an important role in the spectrum of care for war-related PTSD.

References

1.
The violent veterans. Time, March 13, 1972
2.
Kulka R, Schlenger W, Fairbank J, et al: The National Vietnam Veterans Readjustment Study: Tables of Findings and Technical Appendices. New York, Brunner Mazel, 1990
3.
Elbogen EB, Johnson SC, Wagner HR, et al: Violent behaviour and post-traumatic stress disorder in US Iraq and Afghanistan veterans. British Journal of Psychiatry 204:368–375, 2014
4.
MacManus D, Dean K, Jones M, et al: Violent offending by UK military personnel deployed to Iraq and Afghanistan: a data linkage cohort study. Lancet 381:907–917, 2013
5.
Corrigan PW, Watson AC: Findings from the National Comorbidity Survey on the frequency of violent behavior in individualswith psychiatric disorders. Psychiatry Research 136:153–162, 2005
6.
Chemtob CM, Hamada RS, Roitblat HL, et al: Anger, impulsivity, and anger control in combat-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology 62:827–832, 1994
7.
Lasko NB, Gurvits TV, Kuhne AA, et al: Aggression and its correlates in Vietnam veterans with and without chronic posttraumatic stress disorder. Comprehensive Psychiatry 35:373–381, 1994
8.
McFall M, Smith D, Mackay P, et al: Reliability and validity of Mississippi scale for combat-related posttraumatic stress disorder. Psychological Assessment 2:114–121, 1990
9.
Novaco RW, Chemtob CM: Violence associated with combat-related posttraumatic stress disorder: the importance of anger. Psychological Trauma: Theory, Research, Practice, and Policy 7:485–492, 2015
10.
MacManus D, Rona R, Dickson H, et al: Aggressive and violent behavior among military personnel deployed to Iraq and Afghanistan: prevalence and link with deployment and combat exposure. Epidemiologic Reviews 37:196–212, 2015
11.
McFall M, Fontana A, Raskind M, et al: Analysis of violent behavior in Vietnam combat veteran psychiatric inpatients with posttraumatic stress disorder. Journal of Traumatic Stress 12:501–517, 1999
12.
Fontana A, Rosenheck R, Spencer H: The Long Journey Home III: The Third Progress Report on the Department of Veterans Affairs PTSD Clinical Teams Program. West Haven, CT, Northeast Program Evaluation Center, 1993
13.
Rosenheck RA, Fontana A: Post-September 11 admission symptoms and treatment response among veterans with posttraumatic stress disorder. Psychiatric Services 54:1610–1617, 2003
14.
Coker KL, Stefanovics E, Rosenheck R: Correlates of improvement in substance abuse among dually diagnosed veterans with post-traumatic stress disorder in specialized intensive VA treatment. Psychological Trauma: Theory, Research, Practice, and Policy 8:41–48, 2016
15.
Fontana A, Rosenheck R: Effectiveness and cost of the inpatient treatment of posttraumatic stress disorder: comparison of three models of treatment. American Journal of Psychiatry 154:758–765, 1997
16.
Rosenheck R, Fontana A: Impact of efforts to reduce inpatient costs on clinical effectiveness: treatment of posttraumatic stress disorder in the Department of Veterans Affairs. Medical Care 39:168–180, 2001
17.
McLellan AT, Luborsky L, Cacciola J, et al: New data from the Addiction Severity Index: reliability and validity in three centers. Journal of Nervous and Mental Disease 173:412–423, 1985
18.
Fontana A, Rosenheck R: A short form of the Mississippi Scale for measuring change in combat-related PTSD. Journal of Traumatic Stress 7:407–414, 1994
19.
Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ, Erlbaum, 1988
20.
Statistical Software, Version 9.3. Cary, NC, SAS Institute Inc., 2012
21.
Häfner H, Boker W: Crimes of Violence by Mentally Disordered Offenders. Cambridge, Cambridge University Press, 1973
22.
Buchanan A: Criminal conviction after discharge from special (high security) hospital: incidence in the first 10 years. British Journal of Psychiatry 172:472–476, 1998
23.
Bonta J, Law M, Hanson K: The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis. Psychological Bulletin 123:123–142, 1998
24.
Buchanan A, Norko M: Violence risk assessment; in The Psychiatric Report. Edited by Buchanan A, Norko M. Cambridge, United Kingdom, Cambridge University Press, 2011
25.
Greenberg G, Rosenheck R: National Mental Health Program Performance Monitoring System: Fiscal Year 2009 Report. West Haven, CT, Northeast Program Evaluation Center, 2010
26.
Frank R, Glied S: Better but Not Well: Mental Health Policy in the United States Since 1950, 1st ed. Baltimore, John Hopkins University Press, 2008

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Decorative Landscape, Hot Morning Sunlight, by Charles Burchfield, 1916. Transparent watercolor on white wove paper with color notations in graphite. Edward W. Root bequest, Munson-Williams-Proctor Arts Institute, Utica, NY. Photo credit: Munson-Williams-Proctor Arts Institute/Art Resource, New York City.

Psychiatric Services
Pages: 424 - 430
PubMed: 29241432

History

Received: 3 June 2017
Revision received: 2 August 2017
Revision received: 14 September 2017
Accepted: 5 October 2017
Published online: 15 December 2017
Published in print: April 01, 2018

Keywords

  1. Posttraumatic stress disorder (PTSD)
  2. Violence/aggression
  3. Veterans

Authors

Details

Alec Buchanan, Ph.D., M.D. [email protected]
The authors are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Dr. Buchanan is also with the Department of Psychiatry, U.S. Department of Veterans Affairs Connecticut Health Care System, West Haven. Dr. Stefanovics and Dr. Rosenheck are also with the New England VISN 1 Mental Illness Research, Education and Clinical Center, West Haven.
Elina Stefanovics, Ph.D.
The authors are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Dr. Buchanan is also with the Department of Psychiatry, U.S. Department of Veterans Affairs Connecticut Health Care System, West Haven. Dr. Stefanovics and Dr. Rosenheck are also with the New England VISN 1 Mental Illness Research, Education and Clinical Center, West Haven.
Robert A. Rosenheck, M.D.
The authors are with the Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Dr. Buchanan is also with the Department of Psychiatry, U.S. Department of Veterans Affairs Connecticut Health Care System, West Haven. Dr. Stefanovics and Dr. Rosenheck are also with the New England VISN 1 Mental Illness Research, Education and Clinical Center, West Haven.

Notes

Send correspondence to Dr. Buchanan (e-mail: [email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share